ANVS Competitors & Alternatives
Compare Annovis Bio Inc with similar stocks in the same industry
Biotechnology
ANVS
Main Stock$1.92
Tradestie Score
59
Market Cap
$41.51M
Analyst Upside
+551.0%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACHV
Achieve Life Sciences, Inc.
|
$6.52
|
$158.43M | - | 59 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$19.20
|
$154.27M | - | 55 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$13.42
|
$133.50M | - | 58 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.26
|
$114.01M | - | 55 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$25.70
|
$110.20M | - | 59 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$32.13
|
$76.55M | - | 59 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.41
|
$71.69M | - | 55 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$12.02
|
$67.94M | - | 66 | Compare |
|
INMB
INmune Bio Inc. Common stock
|
$1.74
|
$56.63M | - | 51 | Compare |
|
LGVN
Longeveron Inc. Common Stock
|
$0.63
|
$15.64M | - | 52 | Compare |
More ANVS Analysis
Data updated: Jul 08, 2026 | Industry: Biotechnology (SIC 2834)
237 stocks in this industry